Historically Walsall has one of the highest morbidity and mortality rates for coronary heart disease (CHD) in the West Midlands. Morbidity and mortality have fallen in recent years, CHD has been a key priority and there has been significant resources committed to local initiatives in both primary and secondary care. Walsall also leads a Coronary Heart Disease Collaborative across the Black Country. The use of cardiovascular medicines in Walsall is 5% above the regional average with prescribing costs 20% above the regional average.

The Medicines Management Project in Walsall is taking place in three wards within Walsall East PCG, namely Hatherton Rushall, Aldridge Central & South and Aldridge North & Walsall Wood. The population is predominately white Caucasian and there is a mix of affluence in the Aldridge Central & South ward and moderate deprivation in parts of both Hatherton Rushall ward and Aldridge North & Walsall Wood.

There are 6 GP practices participating, ranging from a single handed to a six doctor practice, with a total population of approximately 47,000 patients. Practice pharmacists supporting the implementation of the CHD NSF currently serve all practices. There are seven community pharmacies participating in the project, from health centre pharmacies to high street pharmacies.